Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature is delighted to be hosting Kinase 2016 on 16th and 17th May 2016 in Nottingham

Organised by the SCI’s Fine Chemicals Group and the RSC’s Biological and Medicinal Chemistry sector in partnership with Sygnature Discovery,  Kinase 2016: Next Generation Inhibitors will focus on several pertinent themes including new approaches and technologies to modulate and measure kinase function in addition to diverse medicinal chemistry case studies. The 2 day event includes an impressive line up of speakers, an exhibition, poster presentations and  conference dinner.

Further details can be found here.

Latest News

View All

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’

Sygnature Discovery acquires Peak Proteins

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

Areas of interest

Discovery Discipline
Therapeutic Areas
The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.